Company intelligence / Profile preview
Harmony Biosciences
Plymouth Meeting, Pennsylvania, United Statesharmonybiosciences.com ↗
- Ownership
- Public · HRMY
- Employees
- ~274
- Development stage
- Other
01
Overview
Harmony Biosciences has commercialized pitolisant for narcolepsy in the US and continues to develop next-generation formulations and new compounds targeting additional rare neurological disorders. Clinical results have shown efficacy of pitolisant in reducing excessive daytime sleepiness and cataplexy in narcolepsy patients. Additional programs are at various stages of clinical or preclinical development.
- Therapeutic areas
- Rare DiseasesNeurology
- Modalities
- small molecules (notably pitolisant and other oral compounds)
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
03
Partnerships
Exclusive license with Bioprojet Societe Civile de Recherche for US rights to pitolisant
04
Financials
- Market cap
- $1.9B
- Total revenue
- $868.5M
- Enterprise value
- $1.3B
Beyond the preview
Go deeper on Harmony Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Harmony Biosciences.